Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma
Open Access
- 29 February 2004
- journal article
- Published by Elsevier BV in Cancer Cell
- Vol. 5 (2), 191-199
- https://doi.org/10.1016/s1535-6108(04)00019-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Molecular mechanisms of novel therapeutic approaches for multiple myelomaNature Reviews Cancer, 2002
- Drug resistance and drug development in multiple myelomaSeminars in Oncology, 2002
- Integrins: Bidirectional, Allosteric Signaling MachinesCell, 2002
- CDK Inhibitor p18INK4c Is Required for the Generation of Functional Plasma CellsImmunity, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosisLeukemia, 2002
- The Hallmarks of CancerCell, 2000
- The Role of Adhesion Molecules in Multiple MyelomaActa Haematologica, 1997
- The Proto-Oncogene c-maf Is Responsible for Tissue-Specific Expression of Interleukin-4Cell, 1996
- Terminal differentiation of human bone marrow cells capable of spontaneous and high‐rate immunoglobulin secretion: Role of bone marrow stromal cells and interleukin 6European Journal of Immunology, 1991